PHARMA NORGE AS
Score · fiscal year 2024
83of 100
How to read this: the company is ahead of 97 % of companies in the Morning class Medium in the same sector in 2024. What does this mean?
Rank in the Morning class Medium: 96 of 3,520 · What are Morning company classes?
Place in the whole sector: 544 of 22,333 · Handel
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2024, not a verdict on the company. Based on profitability 95 and solidity 94 out of 100 among companies in the Morning class Medium in the same sector in 2024. Methodology
Against the sector
PHARMA NORGE AS is 33 points above the median for companies in the Morning class Medium in the same sector in 2024.
Median score 50 among 3,520 companies.
Against companies in the Morning class Medium in the same sector in 2024: operating margin 28.0% (median 2.9%) and equity ratio 73.5% (median 30.2%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 55 MNOK | 92 MNOK |
| Operating margin | 28.0% | 2.9% |
| Profit margin | 27.9% | 2.7% |
| Return on assets | 33.0% | 11.8% |
| Equity ratio | 73.5% | 30.2% |
| Debt-to-equity | 0.36 | 2.23 |
| Current ratio | 1.85 | 1.40 |
| Revenue growth | 36.3% | 5.1% |
| Revenue per employee | 2.30 MNOK | 4.92 MNOK |
The median and “ahead of” refer to companies in the Morning class Medium in the same sector in 2024. The bar shows the share of companies the figure is ahead of.
With an index of 83, PHARMA NORGE AS does better than 97% of companies in the Morning class Medium in the same sector (3,520 companies) in 2024.
Score 2023–2025
- PHARMA NORGE AS
- Median: companies in the Morning class Medium in the same sector
What the numbers say
PHARMA NORGE AS had an operating margin of 28.0% and an equity ratio of 73.5% in 2024, and ranks 544 of 22,333 in Handel.
From 2023 to 2024: the operating margin rose from 20.7% to 28.0% and revenue grew by 36%.
This text is generated automatically from the 2024 accounts.
Three simple methods
The methods give between 35 MNOK and 142 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 142 MNOK |
| EV/EBIT | 8.0 | 127 MNOK |
| P/B | 1.0 | 35 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 4.4% of the debt in 2024. The policy rate averaged 4.50 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 95 | weight 30% |
|---|---|---|
| Solidity | 94 | weight 25% |
| Liquidity | 71 | weight 15% |
| Growth | 90 | weight 15% |
| Consistency | 44 | weight 15% |
Durability: 77 (average over 2 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is PHARMA NORGE AS?
The operating margin was 28.0% in 2024, against a median of 2.9% among companies in the Morning class Medium in the same sector. Return on assets was 33.0%.
How solid is PHARMA NORGE AS?
The equity ratio was 73.5% in 2024 (median 30.2%). Debt-to-equity was 0.36 (median 2.23).
What is the liquidity of PHARMA NORGE AS like?
The current ratio was 1.85 in 2024 (median 1.40).
How does PHARMA NORGE AS compare in Handel?
PHARMA NORGE AS ranks 544 of 22,333 in Handel for 2024. Among companies in the Morning class Medium it is number 96 of 3,520. Revenue changed by 36.3% from the year before.
Group accounts
The company is registered as part of a group, but we have no group accounts for it. Group accounts are filed by the parent company, and open data does not say which company that is.
Read the figures with care: a company in a group can look strong because of group contributions, or weak because dividends go up to the parent. The figures are indications, not the full picture.
We do not show the group structure, because open data does not say who owns whom.
From the Central Coordinating Register
- Org. no.
- 919821590
- Legal form
- AS · part of a group
- Sector
- Handel (47.270)
- Morning company class
- Medium
- Employees
- 24 registered 10 September 2026
- Founded
- 1 October 2017 9 years in operation
- Share capital
- 0.29 MNOK
- Business address
- Sørvåg, 8432 ALSVÅG (ØKSNES)
- Municipality
- Øksnes rank 16 of 18 in KOSTRA group 2
- Latest accounts filed
- 2025
- LEI
- 8945005EGFNVH3QLBM25 renews 15 November 2027
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Rune Meyer
- Chair of the board
- Thomas Kristoffer Storvestre
- Auditor
- REVICOM AS
- Accountant
- BOKHOLDERIET AS
- Accountant
- ØKORÅD ØKSNES AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
- Parent company
- Parent does not consolidate the company
Source: GLEIF (Global Legal Entity Identifier Foundation), fetched 31 October 2026. The parent is the one the company itself reported to GLEIF.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 26 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 70 | 83 | 59 | |
| Rank | 4,175 | 544 | 7,606 | |
| Operating margin | 20.7% | 28.0% | 11.9% | |
| Return on assets | 21.7% | 33.0% | 16.4% | |
| Equity ratio | 80.4% | 73.5% | 55.7% | |
| Current ratio | 1.15 | 1.85 | 0.63 | |
| Revenue growth | – | 36.3% | 14.4% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 40.5 MNOK | 55.2 MNOK | 63.1 MNOK |
| Operating profit | 8.4 MNOK | 15.5 MNOK | 7.5 MNOK |
| Profit before tax | 8.7 MNOK | 15.4 MNOK | 8.2 MNOK |
| Net profit | 6.8 MNOK | 14.2 MNOK | 8.1 MNOK |
| Financial expenses | 0.0 MNOK | 0.6 MNOK | 0.4 MNOK |
| Total assets | 40.4 MNOK | 48.3 MNOK | 52.6 MNOK |
| Current assets | 9.1 MNOK | 21.4 MNOK | 14.7 MNOK |
| Equity | 32.5 MNOK | 35.5 MNOK | 29.3 MNOK |
| Retained earnings | 9.4 MNOK | 12.4 MNOK | 6.2 MNOK |
| Total liabilities | 7.9 MNOK | 12.8 MNOK | 23.3 MNOK |
| Current liabilities | 7.9 MNOK | 11.6 MNOK | 23.3 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 6078313.
Further
Similar companies
- VEST TRAKTOR AS index 83, rank 538 · compare
- STIG A DALEN AS index 83, rank 543 · compare
- CONMEC AS index 83, rank 551 · compare
- NORSK MYNTHANDEL AS index 83, rank 553 · compare
- VARNER PE AS index 83, rank 560 · compare